248 related articles for article (PubMed ID: 32237368)
1. [Expert consensus statement on Pudilan Xiaoyan Oral Liquid in clinical practice].
Wang LX; Miao Q; Xie YM; Chen DC; Sun SL; Zhang HC; Jia ZW; Li TN; Zhu J; Shi LQ; Song P; Gao F; Wei BL; Feng CL; Qu YQ; Qu NN; Yu XF; Zhang NZ; Yu XQ
Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(24):5277-5281. PubMed ID: 32237368
[TBL] [Abstract][Full Text] [Related]
2. [Expert consensus statement on Kangfu Xiaoyan Suppository in treatment of pelvic inflammatory in clinical practice].
Wang LX; Hou LH; Xie YM; Ma K; Sun SL; Jin Z; DU HL; Wang DM; Zhao H; Liu YF; Tang L; Shu KY; Zhang CZ; Shi W; Zhan SY; Liu JP; Chen W; Chen YL
Zhongguo Zhong Yao Za Zhi; 2019 Oct; 44(20):4350-4353. PubMed ID: 31872644
[TBL] [Abstract][Full Text] [Related]
3. [Experts consensus statement on Xiyanping Injection in clinical practice(children)].
Wang ZF; Rong P; Ma R; Xie YM; Ding Y; Wang XF; Zhan SY; Li XH
Zhongguo Zhong Yao Za Zhi; 2019 Jul; 44(14):2932-2936. PubMed ID: 31602835
[TBL] [Abstract][Full Text] [Related]
4. [Experts consensus statement on Qilong Capsules in clinical practice].
Wang ZF; Xie YZ; Xie YM; Zhao DX; Wang MZ; Yu HQ; Cao XL; Li B
Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(24):5287-5290. PubMed ID: 32237370
[TBL] [Abstract][Full Text] [Related]
5. [Expert consensus statement on Xiyanping Injection for respiratory system infectious diseases in clinical practice(adults)].
Wang ZF; Zhang HC; Xie YM; Miao Q; Sun ZT; Wang RB; Wang XG; Zhan SY
Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(24):5282-5286. PubMed ID: 32237369
[TBL] [Abstract][Full Text] [Related]
6. [Improvement of compliance of Pudilan Xiaoyan Oral Liquid based on comprehensive analysis of bad taste of traditional Chinese medicine oral liquid preparation].
Dang Y; Meng-Hua J; Liang F; Jun L; Jing Z; E S; Xiao-Bin J
Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(18):4316-4323. PubMed ID: 33164358
[TBL] [Abstract][Full Text] [Related]
7. [Expert consensus on prescription comment of Chinese traditional patent medicine for promoting the rational use of drugs in Beijing].
Jin R; Zhao KJ; Guo GM; Zhang B; Wang YG; Xue CM; Yang YH; Wang LX; Li GH; Tang JF; Nie LX; Zhang XL; Zhao TT; Zhang Y; Yan C; Yuan SZ; Sun LL; Feng XZ; Yan D;
Zhongguo Zhong Yao Za Zhi; 2018 Mar; 43(5):1049-1053. PubMed ID: 29676107
[TBL] [Abstract][Full Text] [Related]
8. [Expert consensus statement on Diemailing~® Kudiezi Injection in clinical practice].
Liao X; Zhang YL; Xie YM; Shi DZ; Sun SL; Zou YH; Li J; Lu WX; Jin M; Liu HX; Tang XC; Jin XL; Ma YZ; Zhan SY; Liu JP; Chen YL
Zhongguo Zhong Yao Za Zhi; 2019 Jul; 44(14):2926-2931. PubMed ID: 31602834
[TBL] [Abstract][Full Text] [Related]
9. [Expert consensus on Injection of Breviscapine in clinical practice].
Li YY; Guo RJ; Xie YM; Lin YM; Cai YF; Zhao JJ; Guo T; Zhang L
Zhongguo Zhong Yao Za Zhi; 2020 May; 45(10):2296-2299. PubMed ID: 32495583
[TBL] [Abstract][Full Text] [Related]
10. [Reporting standards for expert consensus on clinical practice of Chinese patent medicines of China Association of Chinese Medicine].
Mo M; Liao X; Zhang XX; Li B; Chen W; Zhao GZ; Guo YB
Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(12):2644-2651. PubMed ID: 31359735
[TBL] [Abstract][Full Text] [Related]
11. [Product improvement and secondary development of Pudilan Xiaoyan Oral Liquid based on clinical medication].
Dang Y; Meng-Hua J; Hui-Min GU; E S; Liang F; Xiao-Bin J; Jun L; Jing Z; Chao LI
Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(18):4285-4290. PubMed ID: 33164354
[TBL] [Abstract][Full Text] [Related]
12. [Guidance of instructions for compiling expert consensus on clinical practice of Chinese patent medicine of China Association of Chinese Medicine].
Mo M; Zhang XX; Liao X; Li B; Chen W; Zhao GZ; Guo YB
Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(12):2652-2656. PubMed ID: 31359736
[TBL] [Abstract][Full Text] [Related]
13. [Expert consensus statement on treatment of type 2 diabetes with Xiaoke Pills in clinical practice].
Li YY; Ni Q; Xie YM; Zhao JX; Yang XH; Wei JP; Zhang GD; Gao YB; Zhan SY
Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(24):5291-5293. PubMed ID: 32237371
[TBL] [Abstract][Full Text] [Related]
14. [Multidisciplinary expert consensus on the rational use of tetracyclines commonly used in clinical practice].
; ;
Zhonghua Yi Xue Za Zhi; 2023 Aug; 103(30):2281-2296. PubMed ID: 37503588
[TBL] [Abstract][Full Text] [Related]
15. [Expert consensus on Shujin Jianyao Pills in clinical practice].
Liu H; Gao JH; Xie YM; Li YY; Zhang L; Li SH; Xu ZJ; Huang F; Li G; Wang YY
Zhongguo Zhong Yao Za Zhi; 2020 May; 45(10):2300-2303. PubMed ID: 32495584
[TBL] [Abstract][Full Text] [Related]
16. [Source control of Pudilan Xiaoyan Oral Liquid--research on quality of Taraxaci Herba based on ultra high performance liquid chromatography fingerprint].
Chao LI; Xiao-Nan SU; Fa-Gen Z; Fei WU; Wei-Quan BU; Liang F; Xiao-Bin J; Meng-Hua J; E S
Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(18):4307-4315. PubMed ID: 33164357
[TBL] [Abstract][Full Text] [Related]
17. [Expert consensus statement on Hugan Tablets in clinical practice].
Liu H; Wang RB; Xie YM; Li YY; Liao X; Liu SN; Ye YA; Gou CY; Zhan SY; Wang YY
Zhongguo Zhong Yao Za Zhi; 2019 Jul; 44(14):2943-2946. PubMed ID: 31602837
[TBL] [Abstract][Full Text] [Related]
18. [Expert consensus for Jiegu Qili Tablets (Capsules) in treatment of fracture in clinical practice].
Sun K; Xiong H; Yang HJ; Wei X; Zhu LG
Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(7):1976-1981. PubMed ID: 37282974
[TBL] [Abstract][Full Text] [Related]
19. [Expert consensus on clinical application of Wangbi Tablets in treating rheumatoid arthritis and knee osteoarthritis].
Chen WH; Weng XS; Yan XP; Liu W; Jin YH; Lin N; Zhao Y
Zhongguo Zhong Yao Za Zhi; 2021 Sep; 46(17):4569-4574. PubMed ID: 34581063
[TBL] [Abstract][Full Text] [Related]
20. [Expert consensus on clinical application of Lixuwang~® Xuesaitong Soft Capsules].
Jia M; Liang X; Fu GJ; Jin XL; Lu Y; Liao X; Zhang YL
Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(20):5668-5674. PubMed ID: 38114160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
